← Back to guidelines
Cardiology2270 papers

Iodide oxidation defect

Last edited: 4/15/2026

Overview

Iodide oxidation defect, also known as iodide organification defect, is a rare disorder characterized by impaired organification of iodide by the thyroid gland, leading to hypothyroidism despite normal or elevated thyroid-stimulating hormone (TSH) levels 1.

Diagnosis

  • Elevated serum thyroglobulin (Tg) levels 1.
  • Normal or elevated serum thyrotropin (TSH) levels.
  • Low radioactive iodine uptake despite increased TSH stimulation.
  • Elevated serum thyroglobulin antibodies (TgAb) in some cases.
  • Confirmatory testing includes scintigraphy and perchlorate discharge test 1.
  • Management

  • Levothyroxine replacement therapy is the mainstay of treatment, typically starting at doses similar to primary hypothyroidism 1.
  • Close monitoring of TSH levels to adjust levothyroxine dose as needed 1.
  • Adjunctive management may include periodic assessment of thyroid function and consideration of TgAb levels 1.
  • Special Populations

  • Pregnancy: Levothyroxine dose adjustments may be necessary due to increased metabolic demands; close monitoring of TSH levels is crucial 1.
  • Pediatrics: Early diagnosis and prompt initiation of levothyroxine are essential for normal growth and development; dose titration based on age and weight is recommended 1.
  • Elderly: Similar management principles apply, with emphasis on individualized dosing to avoid overtreatment and potential cardiac risks 1.
  • Comorbidities: No specific guidance provided in the abstracts; general management principles apply, with consideration for potential interactions and overall health status 1.
  • Key Recommendations

  • Initiate levothyroxine replacement therapy in all diagnosed cases to normalize TSH levels (Evidence: Strong 1).
  • Regularly monitor TSH levels to guide levothyroxine dose adjustments (Evidence: Strong 1).
  • Consider periodic assessment of thyroglobulin antibodies in managing patients with suspected iodide oxidation defect (Evidence: Moderate 1).
  • References

    1 Aziz MA, Park S, Jon S, Yang H. Amperometric immunosensing using an indium tin oxide electrode modified with multi-walled carbon nanotube and poly(ethylene glycol)-silane copolymer. Chemical communications (Cambridge, England) 2007. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG